Top

Molecular Imaging and Biology

Published in:

01-03-2008 | Research Article

Quantitative Effects of Contrast Enhanced CT Attenuation Correction on PET SUV Measurements

Authors: Tira Bunyaviroch, Timothy G. Turkington, Terence Z. Wong, John W. Wilson, James G. Colsher, R. Edward Coleman

Published in: Molecular Imaging and Biology | Issue 2/2008

Abstract

Purpose

The presence of contrast materials on computed tomography (CT) images can cause problems in the attenuation correction of positron emission tomography (PET) images. These are because of errors converting the CT attenuation of contrast to 511-keV attenuation and by the change in tissue enhancement over the duration of the PET emission scan. Newer CT-based attenuation correction (CTAC) algorithms have been developed to reduce these errors.

Methods

To evaluate the effectiveness of the modified CTAC technique, we performed a retrospective analysis on 20 patients, comparing PET images using unenhanced and contrast-enhanced CT scans for attenuation correction. A phantom study was performed to simulate the effects of contrast on radiotracer concentration measurements.

Results

There was a maximum difference in calculated radiotracer concentrations of 5.9% within the retrospective data and 7% within the phantom data.

Conclusion

Using a CTAC algorithm that de-emphasizes high-density areas, contrast-enhanced CT can be used for attenuation mapping without significant errors in quantitation.

Kinahan PE, Hasegawa BH, Beyer T (2003) X-ray based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med 33:166–179PubMedCrossRef

Kinahan PE, Townsend DW, Beyer T, Sashin D (1998) Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25:2046–2053 (Oct.)PubMedCrossRef

LaCroix KJ, Tsui BMW, Hasegawa BH, Brown JK, et al. (1994) Investigation of the use of x-ray CT images for attenuation compensation in SPECT. IEEE Trans Nucl Sci NS-41:2793–2799CrossRef

Burger C, Goerres G, Schoenes S, Buck A, et al. (2002) PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511 keV attenuation coefficients. Eur J Nucl Med Mol Imag 29:922–927CrossRef

Antoch G, Freudenberg LS, Egelhof T, Stattaus J, et al. (2002) Focal tracer uptake: A potential artifact in contrast enhanced dual-modality PET/CT scans. J Nucl Med 43:1339–1342PubMed

Visvikis D, Costa DC, Croasdale I, Lonn AHR, et al. (2003) CT-based attenuation correction in the calculation of semi-quantitative indices of [18F] FDG uptake in PET. Eur J Nucl Med 30:344–353CrossRef

Nakamoto Y, Chin BB, Kraitchman DL, Lawler LP, et al. (2003) Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. Radiology 227:817–824PubMedCrossRef

Nehmeh SA, Erdi YE, Kalaigian H, Kolbert KS, et al. (2003) Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med 44:1940–1944PubMed

Dizendorf E, Hany TF, Buck A, von Schulthess GK, et al. (2003) Cause and magnitude of the error induced by oral contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 44:732–738PubMed

10.

Antoch G, Jentzen W, Freudenberg LS, Stattaus J, et al. (2003) Effect of oral contrast on computed tomography based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging. Invest Radiol 38:784–789PubMed

11.

Lonn AHR (2003) Evaluation of method to minimize the effect of X-ray contrast in PET-CT attenuation correction. Nuclear Science Symposium Conference Record IEEE 3:2220–2221

12.

Antoch G, Freudenberg LS, Stattaus J, Jentzen W, et al. (2002) Whole body positron emission tomography-CT: Optimized CT using oral and IV contrast materials. AJR 179:1555–1560PubMed

13.

Yau YY, Chan WS, Tam YM, Vernon P, et al. (2005) Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med 46:283–291PubMed

14.

Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Hojgaard L (2005) PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 32:1167–1175PubMedCrossRef

15.

Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, Chu SK (2005) Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med 46:283–291PubMed

16.

Mawlawi O, Erasmus JJ, Munden RF, Pan T, Knight AE, Macapinlac HA, Podoloff DA, Chasen M (2006) Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol 186:308–319PubMedCrossRef

17.

Beyer T, Antoch G, Blodgett T, Freudenberg LF, et al. (2003) Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med 30:588–596CrossRef

18.

Pan T, Mawlawi O, Nehmeh SA, Erdi YE, Luo D, Liu HH, Castillo R, Mohan R, Liao Z, Macapinlac HA (2005) Attenuation correction of PET images with respiration-averaged CT images in PET/CT. J Nucl Med 46:1481–1487PubMed

19.

Weber WA (2005) Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 46:983–995PubMed

Title: Quantitative Effects of Contrast Enhanced CT Attenuation Correction on PET SUV Measurements
Authors: Tira Bunyaviroch
Timothy G. Turkington
Terence Z. Wong
John W. Wilson
James G. Colsher
R. Edward Coleman
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Molecular Imaging and Biology / Issue 2/2008
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-007-0126-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quantitative Effects of Contrast Enhanced CT Attenuation Correction on PET SUV Measurements

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2008

MicroCT Liver Contrast Agent Enhancement Over Time, Dose, and Mouse Strain

Initial Comparison of ntPET with Microdialysis Measurements of Methamphetamine-Induced Dopamine Release in Rats: Support for Estimation of Dopamine Curves from PET Data

The Synthesis of 18F-FDS and Its Potential Application in Molecular Imaging

Semiautomated Radiosynthesis and Biological Evaluation of [18F]FEAU: A Novel PET Imaging Agent for HSV1-tk/sr39tk Reporter Gene Expression

Non-Invasive PET Imaging of EGFR Degradation Induced by a Heat Shock Protein 90 Inhibitor

Performance of Integrated FDG-PET/CT for Differentiating Benign and Malignant Lung Lesions -Results from a Large Prospective Clinical Trial